Clinical observation of the effect of lansoprazole preventin irritable ulcerous hemorrbage in acute cerebral apoplexy

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2002, Vol. 7 ›› Issue (4): 351-352.

Previous Articles Next Articles

Clinical observation of the effect of lansoprazole preventin irritable ulcerous hemorrbage in acute cerebral apoplexy

ZHANG Feng-Lan, ZHAO Jun-He, LI Yan

Second Hospital of Jinan City, Jinan 250001

Received:2002-03-18 Revised:2002-06-20 Online:2002-08-26 Published:2020-11-24

Abstract

CLC Number:

R969.4

ZHANG Feng-Lan, ZHAO Jun-He, LI Yan. Clinical observation of the effect of lansoprazole preventin irritable ulcerous hemorrbage in acute cerebral apoplexy[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(4): 351-352.

[1]	YAN Fei, XIA Chun-hua, XIONG Yu-qing. Effect of CYP2C19 genetic polymorphism on pharmacokinetic characterstics and 5 - hydroxyl metabolic pathway of lansoprazole in Chinese volunteers [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(12): 1397-1401.
[2]	LI Jian-chun, HU Qi-sheng, GAO Shu, JIANG Zhi-wen. Bioequivalence of lansoprazole enterosoluble tablets and capsules in healthy volunteers [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(5): 558-561.
[3]	FU Liang-Qing, HUANG Feng, WU De-Zheng, GUO Jun-Hua. Determination of lansoprazole and its metabolites 5' -hydroxy lansoprazole and lansoprazole sulphone in human plasma by reversed-phase HPLC [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(1): 35-38.

Clinical observation of the effect of lansoprazole preventin irritable ulcerous hemorrbage in acute cerebral apoplexy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 3

Recommended Articles

Metrics

Comments